Alzheimer’s patient groups protest U.S. Medicare coverage proposal limiting use of new drugs
Alzheimer’s patient groups, disappointed by Medicare’s plan to sharply limit coverage of new drugs for the brain-wasting disease, are planning…
Alzheimer’s patient groups, disappointed by Medicare’s plan to sharply limit coverage of new drugs for the brain-wasting disease, are planning…
Biogen’s shares were up 10% at $306 before the bell. If approved, aducanumab would be the first treatment designed to…
A simple blood test can diagnose Alzheimer disease Research, sometimes decades before symptoms even begin. Scientists revealed a protein involved…
Dementia is considered as global health issue due to aging. Number of people suffering with this disease is increasing day…
As the median age of the population increases, the number of individuals with Alzheimer disease (AD) is increasing and their…